Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-10-31, Stock:JNJ, The news for the past five days is as follows:
2018-10-24: NEWS1: Vertex Earnings, Revenue miss in Q3.NEWS2: Recommendations for Allergan on October 24.NEWS3: Stelara and Simponi Drive Johnson & Johnson’s Immunology Business.NEWS4: How Analysts View Johnson & Johnson in October.NEWS5: Allergan’s Q3 2018 Earnings: Analysts’ Estimates.NEWS6: A Performance Overview of Johnson & Johnson.NEWS7: A Performance Overview of Johnson & Johnson’s Surgery Segment.NEWS8: Drug Stocks' Earnings Due on Oct 25: MRK, BMY, GILD & CELG.NEWS9: Drug Stocks' Earnings Due on Oct 25: MRK, BMY, GILD & CELG.NEWS10: Boston Scientific Earnings, Revenue miss in Q3.NEWS11: Drug Stocks&apos; Earnings Due on Oct 25: MRK, BMY, GILD & CELG.NEWS12: Health Care Sector Update for 10/24/2018: LH, ALXN, TMO, JNJ, PFE, ABT, MRK, AMGN.NEWS13: Health Care Sector Update for 10/24/2018: LH, ALXN, TMO, JNJ, PFE, ABT, MRK, AMGN.NEWS14: Thermo Fisher Scientific Earnings, Revenue Beats In Q3.NEWS15: JNJ’s Orthopedics Segment: Knees, Trauma, and Spine.NEWS16: An Overview of Johnson & Johnson’s Orthopedics Business.
2018-10-25: NEWS1: Stryker Earnings beat, Revenue misses In Q3.NEWS2: Gilead Earnings, Revenue beat in Q3.NEWS3: Noteworthy Thursday Option Activity: SHW, LPLA, JNJ.NEWS4: Noteworthy Thursday Option Activity: SHW, LPLA, JNJ.NEWS5: Merck & Co. Grows 5% in the Third Quarter.NEWS6: Notable ETF Inflow Detected - ACWI, MSFT, JNJ, XOM.NEWS7: Notable ETF Inflow Detected - ACWI, MSFT, JNJ, XOM.NEWS8: Celgene Earnings, Revenue beat in Q3.NEWS9: How JNJ’s Invega Sustenna and Risperdal Consta Performed.NEWS10: Merck&Co Earnings beat, Revenue misses In Q3.NEWS11: J&J Intends to Buy Residual Stake in Japanese Skincare Firm.NEWS12: Health Care Sector Update for 10/25/2018: ELGX, BMY, JNJ, PFE, ABT, MRK, AMGN.NEWS13: Health Care Sector Update for 10/25/2018: ELGX, BMY, JNJ, PFE, ABT, MRK, AMGN.NEWS14: How Is Johnson & Johnson’s Neuroscience Business Positioned?.NEWS15: 3 Beaten-Down Biotech Stocks: Can They Bounce Back?.NEWS16: See what the IHS Markit Score report has to say about Johnson & Johnson..NEWS17: An Overview of Johnson & Johnson’s Infectious Diseases Business.NEWS18: How Is Johnson & Johnson’s Vision Care Business Positioned?.NEWS19: The Rally We've Been Waiting For: Cramer's 'Mad Money' Recap (Tuesday 10/16/18).
2018-10-26: NEWS1: Court Issues Ruling in ZYTIGA® Patent Infringement Litigation.NEWS2: Pharma Stock Roundup: MRK, BMY Q3 Earnings, Cancer Data Presentations at ESMO.NEWS3: Pharma Stock Roundup: MRK, BMY Q3 Earnings, Cancer Data Presentations at ESMO.NEWS4: The health and wellness industry is making healthy profits.NEWS5: 'A New Way To Treat The Brain': Stanford University Scientists Launch Cannabis Pharma Company.NEWS6: Celgene’s Revlimid and Pomalyst Saw Solid Q3 Growth.NEWS7: Pharma Stock Roundup: MRK, BMY Q3 Earnings, Cancer Data Presentations at ESMO.NEWS8: How Is JNJ’s Cardiovascular & Metabolism Business Positioned?.NEWS9: Health Care Sector Update for 10/26/2018: SGYP, RARE, JNJ, PFE, ABT, MRK, AMGN.NEWS10: Health Care Sector Update for 10/26/2018: SGYP, RARE, JNJ, PFE, ABT, MRK, AMGN.NEWS11: A Performance Overview of JNJ’s Imbruvica, Velcade, and Zytiga.NEWS12: Johnson & Johnson’s Oncology Business Saw Solid Growth in Q3.
2018-10-29: NEWS1: Johnson & Johnson (JNJ) Gains As Market Dips: What You Should Know.NEWS2: Top Stock Picks for the Week of October 29th.NEWS3: Top Stock Picks for the Week of October 29th.NEWS4: Knock Offs Loom For J&J's Blockbuster — Why An Analyst Is Still Bullish.NEWS5: Biogen And Eisai May Be At Odds In Alzheimer's — So What Now?.NEWS6: Top Analyst Reports for Johnson & Johnson, UnitedHealth, AT&T & Intel.NEWS7: Top Analyst Reports for Johnson & Johnson, UnitedHealth, AT&T & Intel.NEWS8: Top Stock Picks for the Week of October 29th.NEWS9: Top Analyst Reports for Johnson & Johnson, UnitedHealth, AT&T & Intel.NEWS10: GlaxoSmithKline’s Q3 2018 Revenue Expected to Grow.NEWS11: Stocks - RedHat Soars in Pre-market, IBM Falls, Tesla, Ford Jump.NEWS12: Health Care Digest: A small biotech goes head first, Gilead&apos;s lower tax rate and more.NEWS13: What&apos;s in the Cards for Geron (GERN) This Earnings Season?.NEWS14: A Performance Review of JNJ’s Pulmonary Hypertension Business.
2018-10-30: NEWS1: Amgen Earnings, Revenue beat in Q3.NEWS2: Dow Jones Leads Fragile Rebound; Will This Sector Head A Recovery?.NEWS3: Pfizer Missed Analysts’ Third-Quarter Revenue Estimates.NEWS4: Pfizer (PFE) Beats on Q3 Earnings, Meets Sales, Narrows View.NEWS5: Pfizer (PFE) Beats on Q3 Earnings, Meets Sales, Narrows View.NEWS6: HCA Earnings, Revenue beat in Q3.NEWS7: 2 “Forever” Stocks to Grab on This Pullback (paying up to 7.7%).NEWS8: 2 “Forever” Stocks to Grab on This Pullback (paying up to 7.7%).NEWS9: Pfizer Earnings beat, Revenue misses In Q3.NEWS10: The Zacks Analyst Blog Highlights: Johnson & Johnson, UnitedHealth, AT&T and Intel.NEWS11: The Zacks Analyst Blog Highlights: Johnson & Johnson, UnitedHealth, AT&T and Intel.NEWS12: The Zacks Analyst Blog Highlights: Johnson & Johnson, UnitedHealth, AT&T and Intel.

Answer: Decrease